Neos Therapeutics: The Road Ahead
(WorldNews Health)

Maxim 2: A sergeant in motion outranks a lieutenant who doesn`t know what`s going on. -The Seventy Maxims of Maximally Effective Mercenaries` - Howard Tayler It has been a brutal fourth quarter for the biotech sector. The sector entered an `official` bear market towards the end of October, bounced some to begin November but after an eight percent loss during the Friday and Monday trading sessions in the SPDR Biotech ETF (XBI): the sector remains mired in deeply negative investor sentiment and a brutal bear market. One small biopharma that has had a particularly bad go of it is Neos Therapeutics (NEOS). Despite rapid revenue growth in 2018, it has been a brutal time for its investors this...